KINGDEE INT'L (00268) spent HKD 25.5628 million to repurchase 3 million shares on March 31st.
Kingdee International (00268) announced on March 31, 2026 that the company would spend 25.5628 million Hong Kong dollars to buy back 3 million shares at a repurchase price of 8.47-8.55 Hong Kong dollars per share.
KINGDEE INT'L (00268) announced that on March 31, 2026, the company spent 25.5628 million Hong Kong dollars to repurchase 3 million shares, with a repurchase price of 8.47-8.55 Hong Kong dollars per share.
Related Articles
MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.
Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.
CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.
MICROTECH MED-B(02235) invested 641,000 Hong Kong dollars on March 31 to repurchase 88,000 shares.
Shanghai Fosun Pharmaceutical (02196): FXB0871 approved for clinical trials in locally advanced or metastatic solid tumors.
CHINA PENGFEI (03348) released its annual performance with a net profit attributable to shareholders of 101 million yuan, an increase of 50.02% year-on-year.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
